The Systematic Tool to Reduce Inappropriate Prescribing is a method to assess patient's medication and has been incorporated into a clinical decision support system: STRIP Assistant. Our aim was to evaluate the effect of recommendations generated using STRIP Assistant on appropriate prescribing and mortality in a preoperative setting.
| INTRODUCTION
Inappropriate prescribing is common among older people and may have serious consequences, such as inefficacy, adverse drug events, falls, (re)hospitalization or death. [1] [2] [3] [4] [5] The screening tool of older person's prescriptions/screening tool to alert doctors to right treatment (STOPP/START) criteria provide a structured format to evaluate patients' medications for the presence of potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs). 6 Prior research has shown that the use of the STOPP/START criteria improves appropriate prescribing, measured with the Medication Appropriate Index and Assessment of Underutilization Index in a hospital setting. 7 Furthermore, 51.7% of the PIMs that caused a serious adverse drug event were detected when the STOPP/START criteria were used. 2 Lastly, the use of the STOPP/START criteria significantly reduced the number of PIMs and PPOs and the number of falls in a geriatric chronic care facility. 8 Explicit screening tools such as STOPP/START are included in the Systematic Tool to Reduce Inappropriate Prescribing (STRIP).
STRIP consists of 5 steps to optimize an individual patient's medication and has proven to be effective in reducing inappropriate prescribing when used by final-year medical students 9 and in detecting drug-related problems (mainly PIMs) in patients with an intellectual disability. 10 STRIP is currently considered best practice in the Netherlands. 11, 12 A web-based application was developed to help physicians carry out a medication review using the STRIP method: the STRIP Assistant.
STRIP Assistant helps users to formulate medication recommendations based on STOPP/START criteria version 1 and G-standaard. 6, [12] [13] [14] G-standaard is a database comprising all medications registered in the Netherlands, and includes guidelines on established clinical interactions, duplicate medications, contraindications, dosage, and frequency of administration recommendations. The G-standaard forms the basis of pharmacovigilance in the Netherlands. 13 Studies have revealed that the use of STRIP Assistant by general practitioners and pharmacists increases appropriate medication decisions (58-76%), decreases inappropriate decisions (42-24%) and increases the percentage of solved drug-related problems in test cases from general practice. 14, 15 As little is known about the effect of STRIP Assistantgenerated prescribing recommendations in a hospital setting, we evaluated whether prescribing recommendations made with the use of the STRIP Assistant improved prescribing in a preoperative geriatric outpatient population. The primary outcome was the number of resident-implemented medication changes made because of PIMs, PPOs, and suboptimal dosages; a secondary outcome was 3-month postoperative mortality.
What is already known about this subject • The Systematic Tool to Reduce Inappropriate Prescribing (STRIP) Assistant is a clinical decision support system with integrated STOPP/START criteria and other guidelines to allow for a structural and efficient assessment of an individual patient's medication.
• The use of STRIP Assistant by general practitioners and pharmacists in test cases and in patients in general practice increases appropriate decision-making regarding polypharmacy optimization.
What this study adds
• In a preoperative geriatric outpatient clinic, the use of STRIP Assistant resulted in more appropriate prescribing.
• Clinical evaluation including a patient interview is indispensable to integrate patient input and patient data with clinical decision support system-assistance for optimizing the use of multiple medications.
• Future prescribing physicians should start using a clinical decision support system when reviewing patient medication lists in order to investigate the effect on patient related outcomes.
• Clinical decision support systems such as STRIP Assistant promote appropriate prescribing when prescribing recommendations are used in combination with a clinical evaluation.
| METHODS

| Design, setting and participants
This cluster-randomized, controlled trial investigated the effect of written prescribing recommendations generated by a research physician using STRIP Assistant on medication changes made by residents during a preoperative comprehensive geriatric assessment. A cluster randomized design was chosen in order to avoid bias due to residents learning from the recommendations. All residents working at the geriatric outpatient clinic of the University Medical Centre Utrecht during the inclusion period were included except for 3 residents who participated as research physicians in this study. A random number generator randomly assigned the residents to the intervention group (even numbers) and the control group (odd numbers) in a 1:1 ratio.
Owing to the nature of the intervention, residents and the research physicians generating the prescribing recommendations could not be blinded; however, patients, supervisors of the residents and the nurses, who gathered information about comorbidity, cognitive function and functional status, were blinded for the intervention.
Residents from the intervention group were asked not to discuss the prescribing recommendations they received with colleagues, to prevent contamination of the control group. 
| Outcome measures
The primary outcomes were the number of implemented medication 
| Standardization of intervention
To check the accuracy and consistency of the prescribing recommendations generated by the research physician using STRIP Assistant, the (Table 1) . These instructions were applied to all patients included after the first 61 patients (64.4% of control group and 35.4% of intervention group). The effect of these instructions on the primary outcome was investigated.
| Statistical analysis
Differences between intervention and control groups regarding patient characteristics, numbers of PPOs and PIMs at baseline identified with STOPP/START criteria version 2, resident characteristics, and clinical data were analysed using descriptive statistics.
Normally distributed data are presented as means with standard deviations and analysed using t-tests. Non-parametric data are reported as median and interquartile range (IQR) and analysed using the Pearson χ 2 test, Mann-Whitney U test and Fisher exact test.
As a result of the clustered design, generalized estimating equation regression models were used for the primary outcome to adjust Beta-blocker in patients with a history of coronary bypass or coronary stent (myocardial infarction not prerequisite) and ACE inhibitor (only) in patients with history of acute myocardial infarction.
2.
The number of available blood pressure measurements was often limited. Should advice be given on the basis of fewer than 3 measurements?
Antihypertensive medication in patients in whom the target blood pressure was not achieved, regardless of the number of blood pressure measurements. Proton-pump inhibitor pantoprazole or omeprazole as prophylaxis adjusted to 20 mg once daily.
Change in medication:
10. START A7 Should the following medication be changed? Change drug when the patient is not using the firstchoice drug according to guidelines, for example:
10A. Metoprolol instead of propranolol in a patient with a history of myocardial infarction.
10B. Metoprolol instead of sotalol or digoxin in a patient with a history of permanent atrial fibrillation.
10C.
Thiazide diuretic instead of diltiazem in a patient with a history of hypertension.
Other considerations:
11. Is angiotensin inhibitor an alternative when there is an indication for an ACE inhibitor?
Angiotensin inhibitor is considered equivalent to ACE inhibitor. ACE = angiotensin-converting-enzyme; PIM = potentially inappropriate medication; PPO = potential prescribing omission; START = screening tool to alert doctors to right treatment; STOPP = screening tool of older person's prescriptions.
for the numbers of recommended medication changes because of PPOs and PIMs.
Generalized estimating equation regression models were also used to investigate the appropriateness of prescribing according to STOPP/START criteria adjusted for baseline PPOs and PIMs, the effect of the intervention on mortality adjusted for age, sex, and Charlson comorbidity index at screening, and to investigate the effect of the standardization instructions by comparing the control group and the intervention group before and after application of instructions.
To measure any effect of learning or contamination of the control group, the effect of the duration of the residents' participation in the study (in months) on the number of resident-implemented PPO and PIM changes was measured using generalized estimating equation regression models.
Statistical significance levels were set at P < .05 (2 tailed). Statistical analyses were performed using IBM SPSS Statistics version 21
(IBM SPSS, Chicago, IL, USA).
| Sample size
The study size was calculated by assuming that the number of PIM changes made by the resident would be 0.5 per patient in the intervention group and 0.2 per patient in the control group. This was based on a detection rate, using STOPP criteria, of 0.86 in a study involving hospitalized older adults 17 and 0.36 in a study involving primary care patients older than 70 years. 18 
| Ethics
The Research Ethics Committee of University Medical Centre Utrecht confirmed that the Medical Research involving Human Subjects Act was not applicable to this study, and a waiver was granted.
| RESULTS
All 34 randomized residents (i.e. the clusters) participated in the study, 19 were assigned to the intervention group and 15 to the control group; the median number of patients per cluster was 3 (IQR 1-4; Figure 1 ). The trial was ended after the calculated sample size was (Table 2) . Residents in the control group were generally more experienced and were more often specializing in geriatrics, whereas the residents in the intervention group were more often specializing in nursing home medicine ( Table 2 ).
The primary outcome was the number of resident-implemented medication changes made because of PIMs, PPOs and suboptimal dosages.
More recommended PPO and PIM changes were implemented in the intervention group than in the control group (PPOs 26.2% vs 3.4%, P < .001; PIMs 46.2% vs 15.3%, P < .001; Table 3 ). When the In addition to the medication changes because of PPOs, PIMs, and suboptimal dosages, made in accordance with the prescribing recommendations of the research physician with the STRIP Assistant, the residents also identified additional PPO, PIM and suboptimal dosage changes that were not included in the prescribing recommendations ( Figure 2 ). These numbers did not significantly differ between the groups (PPOs 9.3% vs 8.5%, P = 0.843; PIMs 7.7% vs 3.4%, P = .308; suboptimal dosages 4.6% vs 6.8%, P = .603). When combining these additional PPO, PIM and suboptimal dosage changes with the implemented prescribing recommendations, the difference between the total number of PPO and PIM changes made by the residents in the 2 groups remained significant (PPOs 35.4% vs 10.2%, p < .05; PIMs 47.7% vs 16.9%, p < .01; dose adjustment changes 9.2% vs 6.8%, p = .618; Figure 2 ). higher number of medications used by patients in our study (mean 9.5 vs 6-9.5). The fact that we did not find a significant difference in mortality is probably because of the small sample size and the short follow-up period. However, a Cochrane meta-analysis including 3218 patients did not reveal a significant effect of medication review on 1-year mortality rates in hospitalized patients. 21 There is no gold standard to determine the best medication regimen for individual patients. 21 In our study, the individualized prescribing recommendations were considered most appropriate since the STRIP Assistant combines the explicit STOPP/START criteria with other prescribing guidelines, clinical parameters and judgement of an experienced physician. Therefore, the prescribing recommendations provided by the research physician and subsequently implemented by the residents were considered appropriate. Residents within the control group could be expected to make different medication changes or dose adjustments as they did not receive the prescribing recommendations. However, we detected a trend towards more changes additional to the prescribing recommendations in the intervention group than in the control group.
In contrast to the decrease in PIMs, the number of PPOs according to the STOPP/START criteria version 2 did not significantly decrease by the intervention or usual care. However, there was a trend towards less PPOs after the intervention and usual care compared to baseline.
This lack of significance could be due to the fact that the study was not powered for this outcome.
The input for the research physician using the STRIP Assistant was the SHiM use, the medical history, blood pressure, heart rate and estimated glomerular filtration rate. The residents in both groups used information gathered during the comprehensive geriatric assessment.
Consequently, the residents had access to more information than did the research physician who used the STRIP Assistant, such as A potential limitation of this study is that the control group contained more experienced residents, more residents specializing in geriatrics, and fewer residents specializing in nursing home medicine.
This might have caused bias, since there may be a difference in willingness to implement recommendations and a difference in capability to identify inappropriate medication between more and less-experienced residents. Another potential limitation is the variable and small cluster size (median 3), which was determined by the number of patients per resident. Since the objective of this study was to measure the effect of the prescribing recommendations in clinical practice, we decided not to interfere with the working schedule of the residents thereby accepting the variable and small cluster size.
Consensus-based instructions to standardize the prescribing recommendations were introduced during the study, which could have changed the intervention. However, the impact was negligible. When the groups were analysed for the 2 different periods (before and after standardization) the difference between the control group and the intervention group persisted without a significant difference between the intervention group before and after the standardization.
While both the research physicians and residents could have gained experience in generating prescribing recommendations, this learning effect over time was expected to be similar in the 2 groups. Although residents from the intervention group were instructed not to discuss the prescribing recommendations with colleagues, there might have been contamination of the control group due to joined care for other patients with residents from the intervention group. However, this contamination is considered to be minor since most residents worked for only 3-4 months at our centre. Furthermore, the number of resident-implemented recommended PPO and PIM changes did not increase during the participation of the residents in the study. Further research should focus on the effect of prescribing recommendations on clinical, patient-reported and economic outcomes.
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